OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 06/19/2025 at 08:30, 1 year 3 months ago

Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed

Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology
BRIEF

published on 06/18/2025 at 18:05, 1 year 3 months ago

Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
PRESS RELEASE

published on 06/18/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
BRIEF

published on 06/12/2025 at 18:05, 1 year 3 months ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
PRESS RELEASE

published on 06/12/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
BRIEF

published on 06/12/2025 at 08:35, 1 year 3 months ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE

published on 06/12/2025 at 08:30, 1 year 3 months ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
BRIEF

published on 06/11/2025 at 18:05, 1 year 3 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/11/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages

Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF

published on 06/04/2025 at 18:05, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Legislation

Accesswire

Published on 10/03/2026 at 02:35, 21 hours 57 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 6 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 10 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 11 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 11 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 8 hours 47 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 4 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 4 hours ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 6 hours ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 6 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 7 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 2 days 5 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 5 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 6 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE